Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 27;8(4):196-201.
doi: 10.4103/jrpp.JRPP_19_68. eCollection 2019 Oct-Dec.

A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children

Shiva Fatehi  1 , Hamid Eshaghi  2 , Meisam Sharifzadeh  3   4 , Bahador Mirrahimi  5 , Mostafa Qorbani  6 , Parin Tanzifi  7 , Kheirollah Gholami  1 , Toktam Faghihi  1   4
Affiliations

A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children

Shiva Fatehi et al. J Res Pharm Pract. .

Abstract

Objective: Pharmacokinetic and clinical studies recommend applying loading dose of colistin for the treatment of severe infections in the critically ill adults. Pharmacokinetic studies of colistin in children also highlight the need for a loading dose. However, there are no clinical studies evaluating the effectiveness of colistin loading dose in children.

Methods: In a randomized trial, children with ventilator-associated pneumonia or central line-associated bloodstream infection (CLABSI) for whom colistin was initiated, were enrolled. Patients were randomized into two groups; loading dose and conventional dose treatment arms. In the conventional treatment arm, colistimethate sodium was initiated with maintenance dose. In the loading dose group, colistimethate sodium was commenced with a loading dose of 150,000 international unit/kg, then on the maintenance dose. Both treatment arms also received meropenem as combination therapy. Primary outcomes were overall efficacy, clinical improvement and microbiological cure. Secondary outcomes were colistin-induced nephrotoxicity and development of resistance.

Findings: Thirty children completed this study. There was a significantly higher overall efficacy in the group received loading dose (42.9 vs. 6.3%, P = 0.031). There weren't any significant differences in the clinical and microbiological endpoints. In the subgroup of children with CLABSI, results illustrated a trend toward (though statistically nonsignificant) better clinical cure for patients receiving loading dose.

Conclusion: This preliminary study suggests that colistin loading dose might have some benefits in critically ill children, specifically in children with CLABSI. Further trials are required to elucidate colistin best dosing strategy in critically ill children with severe infections.

Keywords: Children; Colistin; clinical efficacy; loading dose; safety.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
CONSORT flow diagram
See this image and copyright information in PMC

References

    1. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–41. - PubMed
    1. Landersdorfer CB, Nation RL. Colistin: How should it be dosed for the critically ill? Semin Respir Crit Care Med. 2015;36:126–35. - PubMed
    1. Thomas R, Velaphi S, Ellis S, Walker AS, Standing JF, Heath P, et al. The use of polymyxins to treat carbapenem resistant infections in neonates and children. Expert Opin Pharmacother. 2019;20:415–22. - PubMed
    1. Nazer LH, Anabtawi N. Optimizing colistin dosing: Is a loading dose necessary? Am J Health Syst Pharm. 2017;74:e9–16. - PubMed
    1. Vardakas KZ, Rellos K, Triarides NA, Falagas ME. Colistin loading dose: Evaluation of the published pharmacokinetic and clinical data. Int J Antimicrob Agents. 2016;48:475–84. - PubMed